CellaVision AB presents the first quarter of 2016 on May 3 at 10:00 CET

The information was submitted to the public on April 21, 2016 at 8:20 CET

CellaVision will publish the interim report for the first quarter on May 3, 2016 at 08:20 CET. The report will be available at www.cellavision.com

In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 10:00 CET where Zlatko Rihter, CEO, will present and comment the report.

The presentation will be in English via a conference call or audio webcast:
http://cloud.magneetto.com/wonderland/2016_0503_Cellavision_Q1_Report/view

Phone number for the conference:
SE: +46 8 566 42 690
UK: +44 2 030 089 808 
US: +1 8 558 315 946

No pre-registration is required. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a timely start.

About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the mother company in Lund and by the market support organizations in the US, Canada, China and Japan. In 2015 sales were SEK 239 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Small Cap list. Read more at www.cellavision.com